Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The National Institute on Drug Abuse (NIDA) seeks research for the discovery and development of medications to prevent and treat opioid use disorder (OUD) and/or psychostimulant (cocaine or methamphetamine) use disorder (PsUD) and overdose.

 

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): Applications will be accepted on a rolling basis, beginning on September 3, 2022. 
  • AIDS Application Due Date(s): Applications will be accepted on a rolling basis, beginning on September 3, 2022. 

PAR-22-200 Expiration Date September 02, 2025

Agency Website

Amount

$15,000,000

Amount Description

Application budgets are limited to $3 million per year for direct costs.

The maximum period of support is 5 years.

      Funding Type

      Grant

      Eligibility

      Faculty

      Category

      Medical
      Medical - Basic Science
      Medical - Clinical Science
      Medical - Translational

      External Deadline

      September 1, 2025